ENTRY       D04765                      Drug
NAME        Lofexidine hydrochloride (USAN);
            Lofexidine (TN);
            Lucemyra (TN)
PRODUCT     LUCEMYRA (USWM)
FORMULA     C11H12Cl2N2O. HCl
EXACT_MASS  294.0093
MOL_WEIGHT  295.5927
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
              DG01450  alpha-Adrenergic receptor agonist
               DG01449  alpha2-Adrenergic receptor agonist
REMARK      ATC code: N07BC04
            Chemical structure group: DG01001
            Product (DG01001): D04765<US>
EFFICACY    Antihypertensive, alpha2-Adrenergic receptor agonist
COMMENT     Mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation
TARGET      ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
  PATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07B DRUGS USED IN ADDICTIVE DISORDERS
                N07BC Drugs used in opioid dependence
                 N07BC04 Lofexidine
                  D04765  Lofexidine hydrochloride (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Anti-Addiction/Substance Abuse Treatment Agents
              Opioid Dependence
               Lofexidine
                D04765  Lofexidine hydrochloride (USAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG01001  Lofexidine
                  D04765  Lofexidine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA2
                 D04765  Lofexidine hydrochloride (USAN) &lt;US&gt;
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D04765
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG01001  Lofexidine
DBLINKS     CAS: 21498-08-8
            PubChem: 47206580
            LigandBox: D04765
            NIKKAJI: J586.627H
ATOM        17
            1   C8x C    27.1048  -17.3043
            2   C8x C    27.1048  -18.7100
            3   C8x C    28.3222  -19.4128
            4   C8y C    29.5396  -18.7100
            5   C8y C    29.5396  -17.3043
            6   C8y C    28.3222  -16.6014
            7   X   Cl   28.3222  -15.1959
            8   X   Cl   30.7757  -19.4239
            9   O2a O    30.7757  -16.5904
            10  C1c C    31.9858  -17.2889
            11  C2y C    33.1729  -16.6033
            12  C1a C    31.9862  -18.7096
            13  N1x N    34.4884  -17.0360
            14  C1x C    35.3055  -15.9197
            15  C1x C    34.4963  -14.7978
            16  N2x N    33.1792  -15.2206
            17  X   Cl   37.0150  -17.9368
BOND        17
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     4   8 1
            9     5   9 1
            10    9  10 1
            11   10  11 1
            12   10  12 1
            13   11  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   11  16 2
///
